abstract |
The invention concerns a series of novel phenoxyacetic acid ethers (and pharmaceutically acceptable salts thereof) of the formula I in which R 1 is H or F, R 2 and R 3 are H or (1-3C)alkyl, Z is CH 2 OH or a group --CO.R 4 in which R 4 is OH, NH 2 or (1-6C)alkoxy. The invention also includes pharmaceutical compositions for use in treating obesity and related conditions and provides processes for the manufacture of the novel ethers. |